Using IPL to treat glaucoma patients with dry eye disease


Steven Vold, MD, founder and CEO of Vold Vision in Northwest Arkansas, shares how his practice uses intense pulsed light (IPL) therapy to treat dry eye disease (DED) in glaucoma patients, during the 2019 American Academy of Ophthalmology annual meeting in San Francisco.

See more content from AAO 2019. 

Related Videos
Moving beyond the drop: CEO provides updates on Oyster Point's pipeline
ViaLase seeks to disrupt glaucoma treatment paradigm with new femtosecond laser treatment
Contralateral eye study investigates iStent vs Hydrus stent for glaucoma
Trukera Medical rebranding allows team to expand into the broader corneal health market
Robot-assisted micro interventional glaucoma surgery reduces surgeon's tremors
© 2023 MJH Life Sciences

All rights reserved.